急性胰腺炎分型与病情评估的研究进展

Clinical advances in acute pancreatitis

急性胰腺炎(AP)是消化科常见急症。由于预后的不同,早期发现急性重症胰腺炎并及时干预非常重要,因此许多临床进展与之有关。介绍了AP两方面的进展,一方面,2012年的亚特兰大分型将重症胰腺炎(SAP)改为中度重症急性胰腺炎(MASP)和重症急性胰腺炎(SAP),是否存在持续48 h的器官衰竭是鉴别MSAP及SAP的关键。另一方面,床旁AP严重度评分作为一种新的AP评分在国内外的研究中得到了肯定的结果。这两方面的进展均体现了人们对AP认识的深入,并可能在将来提高AP患者的预后。

Acute pancreatitis （AP） is a common gastroenterological emergency. Because of the diverse prognosis in AP, it is crucial to identify severe acute pancreatitis （SAP） early and provide timely treatment. Thus, there are a number of clinical advances in this aspect. This paper reviews two advances in AP. Firstly, AP is classified into mild acute panreatitis, moderately severe acute pancreatitis （MSAP）, and SAP according to 2012 revision of the Atlanta Classification; SAP is distinguished from MSAP by the presence of persistent organ failure, that is, organ failure 〉48 h. Secondly, bedside index for severity in acute pancreatitis, a new scoring system, has confirmed value in predicting the severity and prog- nosis of AP both in China and abroad. These advances show more insight into AP and may help to improve the prognosis in AP patients.